By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

I-MAB is a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company's product pipeline includes TJ202, TJ301, TJ107, TJC4, TJD5, and TJM2.

Contact Information

Website: www.i-mabbiopharma.com
Main Phone: +86 2160578000
Address: 88 Shangke Road
Address 2: Suite 802, West Tower, OmniVision
City / Town: Shanghai
Country: CN
Postal Code: 201210

Issuer Information

Exchange: NSD
CEO: Joan Huaqiong Shen
Employees: 185

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A